PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Net Cash Flow (2021 - 2026)

PepGen (PEPG) posted Net Cash Flow of -$18.4 million for Q1 2026, up 77.67% sequentially from -$82.3 million in Q4 2025, and down 217.71% YoY from $15.6 million in Q1 2025.

Analysis

PepGen (PEPG) Net Cash Flow (2021 - 2026) Analysis & Trends

PepGen has reported Net Cash Flow for 6 years, with the latest figure at -$18.4 million in Q1 2026.

  • Quarterly Net Cash Flow fell 217.71% year-over-year to -$18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 98.36% YoY) and the FY2025 annual result came in at $11.1 million, up 135.5% from the prior year.
  • Net Cash Flow advanced to -$18.4 million in Q1 2026 per PEPG's latest filing, from -$82.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $107.7 million in Q3 2025 and troughed at -$82.3 million in Q4 2025.
  • A 5-year average of -$5.3 million and a median of -$16.5 million in 2023 frame the typical range for Net Cash Flow.
  • The sharpest annual moves came in 2022 and 2025: Net Cash Flow surged 1728.72% in 2022, then slumped 1249.85% in 2025.
  • Over 5 years, Net Cash Flow stood at -$14.3 million in 2022, then slumped by 243.23% to -$49.0 million in 2023, then soared by 114.6% to $7.2 million in 2024, then plunged by 1249.85% to -$82.3 million in 2025, then surged by 77.67% to -$18.4 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$18.4 million, -$82.3 million, and $107.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 PepGen 217.99 Mn 217.99 Mn - -19.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.39 Mn
Mar 31, 2026 -18.37 Mn
Dec 31, 2025 -82.26 Mn
Sep 30, 2025 107.70 Mn
Jun 30, 2025 -8.55 Mn
Mar 31, 2025 -5.78 Mn
Dec 31, 2024 7.15 Mn
Sep 30, 2024 -23.82 Mn
Jun 30, 2024 -67.77 Mn
Mar 31, 2024 53.14 Mn
Dec 31, 2023 -48.99 Mn
Sep 30, 2023 -17.24 Mn
Jun 30, 2023 -18.50 Mn
Mar 31, 2023 -16.47 Mn
Dec 31, 2022 -14.27 Mn
Sep 30, 2022 -22.82 Mn
Jun 30, 2022 100.17 Mn
Mar 31, 2022 -13.90 Mn
Dec 31, 2021 -7.17 Mn
Sep 30, 2021 125.20 Mn